Ibrahim Serafi-El

Stockholm, AB 14186, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Optimizing nucleic acid delivery using PF14 peptide and lipid nanoparticle systems.

Optimizing nucleic acid delivery using PF14 peptide and lipid nanoparticle systems.

Journal: International journal of pharmaceutics: X

Published: June 18, 2026

Altered Busulphan Exposure Associated with Concomitant Omeprazole during Hematopoietic Stem Cell Transplantation Conditioning: A Two-Case Report.

Altered Busulphan Exposure Associated with Concomitant Omeprazole during Hematopoietic Stem Cell Transplantation Conditioning: A Two-Case Report.

Journal: Clinical drug investigation

Published: March 06, 2026

Pharmacokinetics and Toxicity of Dimethylacetamide and Its Metabolite in Pediatric Patients Treated With High Dose Intravenous Busulphan.

Pharmacokinetics and Toxicity of Dimethylacetamide and Its Metabolite in Pediatric Patients Treated With High Dose Intravenous Busulphan.

Journal: Clinical and translational science

Published: February 24, 2025

Mechanisms underlying seizures and hypothermia during busulphan administration.

Mechanisms underlying seizures and hypothermia during busulphan administration.

Journal: Bone marrow transplantation

Published: December 25, 2024

Dental pulp stem cells ameliorate D-galactose-induced cardiac ageing in rats.

Dental pulp stem cells ameliorate D-galactose-induced cardiac ageing in rats.

Journal: PeerJ

Published: November 30, 2023

Impact of fludarabine and treosulfan on ovarian tumor cells and mesothelin chimeric antigen receptor T cells.

Impact of fludarabine and treosulfan on ovarian tumor cells and mesothelin chimeric antigen receptor T cells.

Journal: Cancer immunology, immunotherapy : CII

Published: October 23, 2023

Cyclophosphamide Pharmacogenomic Variation in Cancer Treatment and Its Effect on Bioactivation and Pharmacokinetics.

Cyclophosphamide Pharmacogenomic Variation in Cancer Treatment and Its Effect on Bioactivation and Pharmacokinetics.

Journal: Advances in pharmacological and pharmaceutical sciences

Published: September 04, 2023

Tuned activation of MSLN-CAR T cells induces superior antitumor responses in ovarian cancer models.

Tuned activation of MSLN-CAR T cells induces superior antitumor responses in ovarian cancer models.

Journal: Journal for immunotherapy of cancer

Published: December 22, 2022

A Systematic Review of Keratinocyte Secretions: A Regenerative Perspective.

A Systematic Review of Keratinocyte Secretions: A Regenerative Perspective.

Journal: International journal of molecular sciences

Published: April 29, 2022

Biomaterials as a Vital Frontier for Stem Cell-Based Tissue Regeneration.

Biomaterials as a Vital Frontier for Stem Cell-Based Tissue Regeneration.

Journal: Frontiers in cell and developmental biology

Published: May 24, 2021

Mesothelin-Specific CAR T Cells Target Ovarian Cancer.

Mesothelin-Specific CAR T Cells Target Ovarian Cancer.

Journal: Cancer research

Published: August 20, 2020

Vitamin D levels and busulphan kinetics in patients undergoing hematopoietic stem cell transplantation, a multicenter study.

Vitamin D levels and busulphan kinetics in patients undergoing hematopoietic stem cell transplantation, a multicenter study.

Journal: Bone marrow transplantation

Published: May 14, 2020

Showing 1-12 of 24

Last Updated: 09/26/2026